Jinan Guo

940 total citations
38 papers, 608 citations indexed

About

Jinan Guo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jinan Guo has authored 38 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Jinan Guo's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Jinan Guo is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Jinan Guo collaborates with scholars based in China, Sweden and United States. Jinan Guo's co-authors include Kefeng Xiao, Yeqing Yuan, Chang Zou, Jiansheng Huang, Jing Xie, Xueqi Zhang, Lingyun Dai, Zaishang Li, Zhangang Xiao and Zhiqiang Cheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pharmacology & Therapeutics and Life Sciences.

In The Last Decade

Jinan Guo

36 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinan Guo China 16 343 196 187 150 70 38 608
Cristina Pérez-Ramírez Spain 14 309 0.9× 177 0.9× 161 0.9× 211 1.4× 108 1.5× 50 762
Jason M. Foulks United States 14 428 1.2× 152 0.8× 64 0.3× 114 0.8× 105 1.5× 31 850
William Tse United States 17 419 1.2× 116 0.6× 124 0.7× 159 1.1× 109 1.6× 50 905
Yusuke Imamura Japan 15 315 0.9× 169 0.9× 399 2.1× 154 1.0× 41 0.6× 77 765
Youwei Bi United States 14 225 0.7× 89 0.5× 307 1.6× 275 1.8× 55 0.8× 25 768
Yiqian Liu China 17 514 1.5× 370 1.9× 204 1.1× 213 1.4× 46 0.7× 53 881
Raimondo Di Liello Italy 13 265 0.8× 113 0.6× 228 1.2× 357 2.4× 87 1.2× 33 738
Yinghua Pan China 16 376 1.1× 225 1.1× 120 0.6× 108 0.7× 34 0.5× 21 609
Annalisa Lorenzato Italy 13 369 1.1× 234 1.2× 117 0.6× 137 0.9× 69 1.0× 22 698
Peide Bai China 12 265 0.8× 237 1.2× 151 0.8× 104 0.7× 24 0.3× 31 499

Countries citing papers authored by Jinan Guo

Since Specialization
Citations

This map shows the geographic impact of Jinan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinan Guo more than expected).

Fields of papers citing papers by Jinan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinan Guo. The network helps show where Jinan Guo may publish in the future.

Co-authorship network of co-authors of Jinan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinan Guo. A scholar is included among the top collaborators of Jinan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinan Guo. Jinan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Haitao, Xiaoxian Wang, Xin Sun, et al.. (2025). A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy. Acta Pharmaceutica Sinica B. 15(6). 3243–3258. 2 indexed citations
2.
Xie, Jing, et al.. (2024). The urinary microbiota composition and functionality of calcium oxalate stone formers. Frontiers in Cellular and Infection Microbiology. 14. 1394955–1394955.
3.
Chen, Junhui, Qian Zhang, Jinan Guo, et al.. (2024). Single-cell transcriptomics reveals the ameliorative effect of rosmarinic acid on diabetic nephropathy-induced kidney injury by modulating oxidative stress and inflammation. Acta Pharmaceutica Sinica B. 14(4). 1661–1676. 18 indexed citations
4.
Guo, Jinan, Xiaoshi Ma, Dongcheng Liu, et al.. (2024). A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug Resistance Updates. 76. 101116–101116. 15 indexed citations
5.
6.
Liu, Pengyu, Wenxuan Wang, Fei Wang, et al.. (2023). Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Journal of Translational Medicine. 21(1). 40–40. 32 indexed citations
7.
Chen, Lipeng, Tao Chen, Kun Chen, et al.. (2023). Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer. Computational and Structural Biotechnology Journal. 21. 5476–5490. 4 indexed citations
8.
9.
He, Zhijun, et al.. (2022). Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells. Cell Communication and Signaling. 20(1). 194–194. 18 indexed citations
10.
Sun, Jichao, Nayana Prabhu, Jun Tang, et al.. (2021). Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules. Medicinal Research Reviews. 41(6). 2893–2926. 22 indexed citations
11.
Ma, Xiaoshi, Jinan Guo, Kaisheng Liu, et al.. (2020). Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Molecular Cancer. 19(1). 147–147. 61 indexed citations
12.
Xie, Jing, et al.. (2020). Profiling the urinary microbiome in men with calcium-based kidney stones. BMC Microbiology. 20(1). 41–41. 55 indexed citations
13.
Jiang, Hongtao, Jinan Guo, Jiansheng Huang, et al.. (2020). CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD. BioMed Research International. 2020(1). 7638975–7638975. 27 indexed citations
14.
Zhang, Xinyue, Jinan Guo, Parham Jabbarzadeh Kaboli, et al.. (2020). <p>Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 7295–7304. 25 indexed citations
15.
Dai, Lingyun, Zhijie Li, Dan Chen, et al.. (2020). Target identification and validation of natural products with label-free methodology: A critical review from 2005 to 2020. Pharmacology & Therapeutics. 216. 107690–107690. 37 indexed citations
16.
Guo, Jinan, Xuhui Zhang, Heather Johnson, et al.. (2020). Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification. Frontiers in Cell and Developmental Biology. 8. 597961–597961. 12 indexed citations
17.
Guo, Jinan, Yanfeng Liu, Yeqing Yuan, et al.. (2018). Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis. International Journal of Surgery. 60. 216–223. 47 indexed citations
18.
Guo, Jinan, et al.. (2016). Diagnosis and surgical treatment of obstructive azoospermia due to iatrogenic vas duct injury. Zhonghua miniao waike zazhi. 37(1). 52–56. 1 indexed citations
19.
Xiao, Kefeng, Jinan Guo, Xuhui Zhang, et al.. (2016). Use of two gene panels for prostate cancer diagnosis and patient risk stratification. Tumor Biology. 37(8). 10115–10122. 8 indexed citations
20.
Lai, Caiyong, Bin Pan, Yun Luo, et al.. (2014). Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma. Molecular Biology Reports. 41(6). 3651–3657. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Pérez-Ramírez Breakdown of academic impact, for papers by Jason M. Foulks Breakdown of academic impact, for papers by William Tse Breakdown of academic impact, for papers by Yusuke Imamura Breakdown of academic impact, for papers by Youwei Bi Breakdown of academic impact, for papers by Yiqian Liu Breakdown of academic impact, for papers by Raimondo Di Liello Breakdown of academic impact, for papers by Yinghua Pan Breakdown of academic impact, for papers by Annalisa Lorenzato Breakdown of academic impact, for papers by Peide Bai
Rankless by CCL
2026